Quantitative exploration of possible reasons for the recent improvement in breast cancer survival

[1]  D. Kopans.  The effect of changes in tumor size on breast carcinoma survival in the U.S. , 2006, Cancer.

[2]  L. Huiart,et al.  Amélioration de la survie après cancer du sein : analyse d’une cohorte de 5 722 patientes traitées de 1975 à 2003 dans un centre de lutte contre le cancer , 2006 .

[3]  Ingvar Andersson,et al.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study , 2006, BMJ : British Medical Journal.

[4]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[5]  J. Goodwin,et al.  Comorbid disease and cancer: the need for more relevant conceptual models in health services research. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Begg,et al.  The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999 , 2005, Cancer.

[7]  Yu Shen,et al.  Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. , 2005, Journal of the National Cancer Institute.

[8]  J. Lemaire,et al.  The benefit of participating to clinical research , 2005, Breast Cancer Research and Treatment.

[9]  J. Ioannidis,et al.  RESPONSE: Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis , 2005 .

[10]  M. Venturini,et al.  ATAC trial update , 2005, The Lancet.

[11]  A. Ugnat,et al.  Survival patterns for the top four cancers in Canada: the effects of age, region and period , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[12]  J. Coebergh,et al.  Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.

[13]  Peter J. Huber,et al.  Wiley Series in Probability and Mathematics Statistics , 2005 .

[14]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[15]  Eva Negri,et al.  Trends in mortality from major cancers in the European Union, including acceding countries, in 2004 , 2004, Cancer.

[16]  G. Vlastos,et al.  Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries , 2004, BMC Cancer.

[17]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[18]  G. Nagel,et al.  The impact of comorbidity on the survival of postmenopausal women with breast cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[19]  R. Govindan,et al.  Differential prognostic impact of comorbidity. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Edward L Spitznagel,et al.  Prognostic importance of comorbidity in a hospital-based cancer registry. , 2004, JAMA.

[21]  J. Coebergh,et al.  Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.

[22]  L. Ellison,et al.  Leading cancers--changes in five-year relative survival. , 2004, Health reports.

[23]  M. Coleman,et al.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  E Carrani,et al.  The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Quinn Mj.  Cancer Trends in the United States—A View From Europe , 2003 .

[26]  M. Coleman,et al.  Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe , 2003, International journal of cancer.

[27]  Gordon Johnston,et al.  Statistical Models and Methods for Lifetime Data , 2003, Technometrics.

[28]  Joann G. Elmore,et al.  Mammographic Screening for Breast Cancer , 2003 .

[29]  A. Miller,et al.  Why is breast-cancer mortality declining? , 2003, The Lancet. Oncology.

[30]  J W Gamel,et al.  Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients , 2001, Statistical methods in medical research.

[31]  R Yancik,et al.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. , 2001, JAMA.

[32]  Stephen MacMahon,et al.  Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies , 2001, The Lancet.

[33]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[34]  T. Reynolds.  Declining breast cancer mortality: what's behind it? , 1999, Journal of the National Cancer Institute.

[35]  K. Gelmon,et al.  Adjuvant systemic therapy and survival after breast cancer. , 1994, The New England journal of medicine.

[36]  W. Odling-Smee,et al.  Screening for Breast Cancer , 1985, The Lancet.

[37]  J. Lawless.  Statistical Models and Methods for Lifetime Data , 1983 .

[38]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[39]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[40]  V. Bardou,et al.  [Improvement in breast cancer survival between 1975 and 2003 in a cohort of 5722 women]. , 2006, Bulletin du cancer.

[41]  E. Kliewer,et al.  Breast cancer trends in Manitoba: 40 years of follow-up. , 2005, Chronic diseases in Canada.

[42]  Shunzo Kobayashi,et al.  What caused the decline in breast cancer mortality in the united kingdom? , 2004, Breast cancer.

[43]  Terry L. Smith,et al.  Is breast cancer survival improving? , 2004, Cancer.

[44]  M. Quinn.  Cancer trends in the United States--a view from Europe. , 2003, Journal of the National Cancer Institute.

[45]  Joann G Elmore,et al.  Clinical practice. Mammographic screening for breast cancer. , 2003, The New England journal of medicine.

[46]  K. Kerlikowske,et al.  Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. , 1997, Journal of the National Cancer Institute. Monographs.

[47]  M. Coleman,et al.  Basic issues in estimating and comparing the survival of cancer patients. , 1995, IARC scientific publications.